CG Oncology, Inc. Common stock (CGON) Stock
NASDAQ · CGON
74.62
Fundamentals
Market cap
$6.61B
Price / Earnings ratio
-29.9x
Price / Sales ratio
1076.3x
Price / Book ratio
6.5x
Return on assets
-0.2%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About CG Oncology, Inc. Common stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees142
CEOMr. Arthur Kuan
IPO DateJan 25, 2024
HeadquartersDallas, TX
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Arthur Kuan | President, Chairman & CEO | 1991 |
| Mr. James M. DeTore | Chief Financial Officer | 1965 |
| Mr. Joshua F. Patterson | General Counsel, Chief Compliance Officer & Secretary | 1977 |
| Dr. Vijay Kasturi M.D. | Chief Medical Officer | 1968 |
| Mr. Swapnil Bhargava Ph.D. | Chief Technical Officer | — |
| Ms. Amy Steele | Vice President of Finance & Administration | — |
| Ms. Sarah Connors | Vice President of Communications & Patient Advocacy | — |
| Mr. Bing Kung | Vice President of Corporate Development | — |
Fundamentals
Valuation
Market cap$6.61B
Price-to-sales ratio1,076.27
Price-to-book value6.51
Price-earnings ratio-29.90
Return on Equity-23.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-2.69
Income Statement
Average volume699,230
EBITDA$-184.42M
1 year high (52w)$80.97
1 year low (52w)$35.64
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



